Narratives Can Help Science Counter Misinformation on Vaccines

 Iowa State University
13-Apr-2021 12:50 PM EDT, by Iowa State University

Newswise — AMES, Iowa – Narratives are a powerful tool that can help explain complex issues, but they can also serve as sources of misinformation, which presents a challenge as public health agencies work to educate people about COVID-19 vaccine. 

In a paper published by the Proceedings of the National Academy of Sciences, author Michael Dahlstrom, a professor and director of Iowa State University’s Greenlee School of Journalism and Mass Communication, examined how narratives or storytelling can help counter misinformation and provide a connection between science and the human experience. Dahlstrom says simply presenting the facts, without some connection, may not help people make informed decisions. 

“If the person doesn’t have the context, background or experience to connect facts in accurate ways, you’re basically giving them puzzle pieces that might not fit together and then expecting them to make a clear picture,” he said. “In science, which is often complicated, it can be helpful to present the facts and show how they connect, so people see the broader landscape in an accurate way to make a decision.”

That’s important because narratives often have a disproportionate influence on attitudes and behaviors, when contrasted with scientific information. This is true whether the narrative is about vaccines, climate change or any other topic. Dahlstrom says we are hardwired to make sense of the world around us, and stories are the primary structure we use to make those connections.

For example, a story about how the COVID-19 vaccine is allowing families to reconnect after months apart is more persuasive and compelling than explaining how the vaccine works and its efficacy, Dahlstrom said. However, he cautions that stories won’t always have an impact. On controversial issues, there will be people on both extremes who align with stories that confirm what they believe and attack stories counter to their beliefs. 

As Dahlstrom explained in the paper, research has shown that audiences have a difficult time identifying errors in narratives and will generally accept those errors as fact. Even when people know a story is misleading or incorrect, they still tend to believe it, rather than disregard. That is why presenting an equally compelling narrative may be more effective than trying to counter that misinformation with facts alone. 

“Narratives can be the cause and remedy of scientific misinformation. It really depends on how the narrator incorporates science in the message. Taking the facts and connecting them in a way that show human experiences add up over time,” Dahlstrom said. “The connections built by stories tend to embed themselves into the connections you’ve already made in your head. They are then deeply connected to other experiences, which is why they’re powerful.”

Dahlstrom says one final takeaway is that stories or narratives are not anti-science, which is often the perception of scientists. It’s how the author crafts the story or uses the narrative that is often the problem. 

SEE ORIGINAL STUDY



Filters close

Showing results

1120 of 5849
Released: 17-Jun-2021 1:30 PM EDT
Hackensack Meridian Doctors, Student Help Establish Way to Prioritize Surgeries During COVID-19 lockdown
Hackensack Meridian Health

The MeNTS method of prioritizing surgeries during the height of pandemic, developed by University of Chicago, helped procedures continue during time of need

Released: 17-Jun-2021 12:55 PM EDT
‘Nanodecoy’ Therapy Binds and Neutralizes SARS-CoV-2 Virus
North Carolina State University

Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19.

access_time Embargo lifts in 2 days
Embargo will expire: 21-Jun-2021 11:00 AM EDT Released to reporters: 17-Jun-2021 12:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-Jun-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Blood Cancer Patients with COVID-19 Fare Better with Convalescent Plasma
Released: 17-Jun-2021 11:55 AM EDT
Blood Cancer Patients with COVID-19 Fare Better with Convalescent Plasma
Washington University in St. Louis

A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus. The therapy involves transfusing plasma — the pale yellow liquid in blood that is rich in antibodies — from people who have recovered from COVID-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalized with the viral infection.

Released: 17-Jun-2021 11:05 AM EDT
Stress during pandemic linked to poor sleep
Washington State University

Many people likely lost sleep over COVID-19. A study of twins led by Washington State University researchers found that stress, anxiety and depression during the first few weeks of the pandemic were associated with less and lower quality sleep.

Newswise:Video Embedded university-of-miami-miller-school-study-shows-covid-19-mrna-vaccines-do-not-impact-male-fertility
VIDEO
Released: 17-Jun-2021 11:00 AM EDT
University of Miami Miller School Study Shows COVID-19 mRNA Vaccines Do Not Impact Male Fertility
University of Miami Health System, Miller School of Medicine

The Pfizer and Moderna mRNA COVID-19 vaccines is safe for male reproduction, according to a new study by University of Miami Miller School of Medicine researchers published in JAMA , the most widely circulated general medical journal in the world.

15-Jun-2021 1:20 PM EDT
Higher COVID-19 Mortality Among Black Patients Linked to Unequal Hospital Quality
Perelman School of Medicine at the University of Pennsylvania

If Black patients were admitted to the same hospitals that serve a majority of White patients, researchers showed their risk of death would drop by 10 percent

Released: 17-Jun-2021 9:35 AM EDT
Hackensack Meridian CDI Scientists Develop ‘CATCHER’ for Crucial Biomarkers
Hackensack Meridian Health

The EV-CATCHER methodology identifies and captures tiny pieces of genetic material – and shows value in COVID-19 plasma

Newswise: “ChulaCov19” Thailand’s First COVID-19 Vaccine Has Been Tested on Humans
Released: 17-Jun-2021 8:55 AM EDT
“ChulaCov19” Thailand’s First COVID-19 Vaccine Has Been Tested on Humans
Chulalongkorn University

On June 14, 2021 at Bhumisirimangalanusorn Building, Chulalongkorn Memorial Hospital, the Thai Red Cross Society, the Faculty of Medicine and the Chula Vaccine Research Center (CVRC), Faculty of Medicine, Chulalongkorn University conducted its first phase of clinical trial on volunteers who have passed the screening process and deemed to be in good health. The process is continuing on to phase 2 to monitor immunity reactions to the ChulaCov19 vaccine under the supervision of medical experts, doctors, nurses and the research team.

16-Jun-2021 5:00 AM EDT
Disadvantaged Neighborhoods See More COVID-19 Infections and Deaths, Mount Sinai Scientists Report
Mount Sinai Health System

New York City neighborhoods that had higher levels of socioeconomic disadvantage experienced more COVID-19 infections and deaths, according to Mount Sinai scientists who created a neighborhood-level COVID-19 inequity index.


Showing results

1120 of 5849

close
1.31462